Investor Update

Basel, 06 December 2018

Chugai Receives Orphan Drug Designation for TECENTRIQ® in Small cell Lung Cancer and for Entrectinib in NTRK Fusion-positive Solid Tumors

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.